Location: Home
  • search
  • go
  • Relate News
  • 9/29/2021HUTCHMED Closes Divestment of Non-Core Chinese OTC Joint Venture
  • 9/29/2021Zhaoke Ophthalmology's Chinese IND for Potential First Myopia Drug NVK...
  • 9/29/2021iX Biopharma Enters Deal with China Resources Pharma for ED Drug Wafe...
  • 9/28/2021JW Therapeutics Granted Chinese Approval of T-Cell Therapy for Large B...
  • 9/28/2021NHSA Completes Expert Review of Product Applications for 2021 NRDL
  • 9/28/2021Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti...
  • 9/28/2021I-Mab's Chinese IND Accepted for P2 Trial of Enoblituzumab in Combo wi...
  • 9/28/2021Genelux and Newsoara Announce License Deal for Oncolytic Immunotherapi...
  • 9/28/2021China's "Hatch-Waxman" System: A Comparative Overview
  • 9/27/2021CDE Solicits Public Comments on Draft of the Technical Guidelines for ...
  • 9/27/2021CDE Solicits Public Comments on Draft of the Technical Guidelines for ...
  • 9/27/2021JW Therapeutics Granted Chinese IND Approval for Multiple Myeloma CAR ...
  • 9/27/2021Bio-Thera and Intract Pharma Enter License Pact for Soteria and Phlora...
  • 9/27/2021Innovent and UNION Therapeutics Enter License Deal for Next-generation...
  • 9/27/2021Beijing Wantai to Initiate Trial for Nasal Spray COVID-19 Vaccine Cand...
  • 9/27/2021Neurophth Completes GMP Manufacturing Facility for Gene Therapy Produ...
  • 9/27/2021Transcenta Cleared for Chinese IND of Anti-sclerostin mAb TST002
  • 9/24/2021Everest Medicines Announces IND Approval of Class 1 Anti-infective SPR...
  • 9/24/2021Akeso's Chinese NDA for Cadonilimab Accepted by NMPA
  • 9/24/2021Healthcare Units of Chinese IT Giants Under Pressure As State Media C...
  • 9/24/2021Review of Performance Results of Listed Chinese Pharma Companies H1/20...
  • 9/24/2021Review of R&D Investments of Selected Listed Chinese Pharma Companies ...
  • 9/24/2021Snapshot of BMI System Financial Performance in H1/2021
  • 9/24/2021Recent Executive Moves
  • 9/23/2021Sihuan/Xuanzhu and SignalChem Announce Licensing Deal for SLC-391 in G...
  • 9/23/2021Guangzhou Pharma Eyes Public Listing of Subsidiaries
  • 9/23/2021Cytiva Triples Bioprocessing Single-Use Consumables Capacity in China
  • 9/23/2021Scopus Granted Chinese Patent for CpG-STAT3 Inhibitor DUET-02
  • 9/23/2021Innovent's sNDA for Sintilimab in Combo with Chemotherapy as First-L...
  • 9/23/2021Prevalence of Depressive Disorders and Treatment in China: A Cross-Sec...
  • Page:183/789 Total number of articles:23668: [First][<<] [181] [182] [183] [184] [185] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group